noom glp-1 side effects Microdosing for Weight Loss Noom’s New Microdose GLP-1 Program

Methods Adults (18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index

This patch helps suppress hunger and maintain energy levels, making fasting windows more manageable and sustainable

It is not approved for any of these yet, but the intent is clearly broader metabolic health, not just weight loss

Patients with 6 months of treatment with GLP1-RA, up until November 2021, due to weight regain after bariatric surgery were identified

GLP-1 is a medication used for weight loss, to treat type 2 diabetes and to reduce the risk of major adverse cardiovascular events